{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"2.6","upperLimit":"5.6","value":"4.6"},{"groupId":"OG001","lowerLimit":"0.7","upperLimit":"7.0","value":"4.6"},{"comment":"The median and the upper limit was not estimable due to a small sample size and 2 participants had PD or Death.","groupId":"OG002","lowerLimit":"2.9","upperLimit":"NA","value":"NA"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"11"},{"groupId":"OG002","value":"6"}],"units":"Participants"}],"description":"The duration of response was measured from the time measurement criteria were first met for a CR or PR (whichever was first recorded) until the first date of objectively documented progressive disease (taking as a reference for progressive disease the smallest measurement recorded since randomization) or the date of death, whichever occurred first. Data for participants who did not relapse or die were censored at the day of their last adequate tumor assessment. Duration of response was estimated by the Kaplan-Meier method.","dispersionType":"95% Confidence Interval","groups":[{"description":"Cycles repeat every 3 weeks until disease Progression, unacceptable toxicity, or withdrawal.\n\nDocetaxel: 75 mg/m2 on Day 1 of each 21-day cycle","id":"OG000","title":"Docetaxel"},{"description":"Cycles repeat every 3 weeks until disease Progression, unacceptable toxicity, or withdrawal.\n\nDocetaxel: 75 mg/m2 on Day 1 of each 21-day cycle\n\nRamucirumab (DP): 10 mg/kg IV on day 1 of each 21-day cycle","id":"OG001","title":"Docetaxel + Ramucirumab DP"},{"description":"Cycles repeat every 3 weeks until disease Progression, unacceptable toxicity, or withdrawal.\n\nDocetaxel: 75 mg/m2 on Day 1 of each 21-day cycle\n\nIcrucumab: 12 mg/kg IV on day 1 and Day 8 of each 21-day cycle","id":"OG002","title":"Docetaxel + Icrucumab"}],"paramType":"MEDIAN","populationDescription":"All randomized participants received one dose of study drug and had CR or PR.","reportingStatus":"POSTED","timeFrame":"First Criteria Met for CR or PR to Measured PD or Death From Any Cause (Up to 40 Months)","title":"Duration of Response","type":"SECONDARY","unitOfMeasure":"months"}